(Q40813465)

24 September 2017

1 reference

title

New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitors (English)

1 reference

24 September 2017

E F Foote

1

1 reference

24 September 2017

C E Halstenson

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 December 1993

1 reference

Annals of Pharmacotherapy

24 September 2017

published in

1 reference

24 September 2017

volume

27

1 reference

24 September 2017

issue

12

1 reference

24 September 2017

page(s)

1495-1503

1 reference

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. A research review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Significance of the vascular renin-angiotensin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Nonpeptide angiotensin II receptor antagonists. IV. EXP6155 and EXP6803.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

A study of the renin inhibitor H142 in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Ro 42-5892 is a potent orally active renin inhibitor in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Renin release regulation during acute renin inhibition in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

Angiotensin converting enzyme (ACE) inhibitors and renal function. A review of the current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302701216

10.1177/106002809302701216

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference